The FDA recently released a Topamax warning to notify patients and healthcare providers about elevated risk of birth defects in infants whose mothers were treated with Topamax during the first trimester of pregnancy. Topamax lawyers are available for mothers treated with Topamax during pregnancy with children born with birth defects.